53 related articles for article (PubMed ID: 35956864)
21. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents.
Tian C; Chen X; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2019 Dec; 183():111679. PubMed ID: 31541870
[TBL] [Abstract][Full Text] [Related]
22. Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities.
Yang F; Yu LZ; Diao PC; Jian XE; Zhou MF; Jiang CS; You WW; Ma WF; Zhao PL
Bioorg Chem; 2019 Nov; 92():103260. PubMed ID: 31525523
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Novel Bcl-2 Inhibitor by Ligand-Based Screening and Investigation of Its Anti-cancer Effect on Human Breast Cancer Cells.
Wen M; Deng ZK; Jiang SL; Guan YD; Wu HZ; Wang XL; Xiao SS; Zhang Y; Yang JM; Cao DS; Cheng Y
Front Pharmacol; 2019; 10():391. PubMed ID: 31057406
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives.
Sreenivasulu R; Reddy KT; Sujitha P; Kumar CG; Raju RR
Bioorg Med Chem; 2019 Mar; 27(6):1043-1055. PubMed ID: 30773423
[TBL] [Abstract][Full Text] [Related]
25. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins.
Singh R; Letai A; Sarosiek K
Nat Rev Mol Cell Biol; 2019 Mar; 20(3):175-193. PubMed ID: 30655609
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of alkyl substituted pyridino[2,3-D]pyrimidine compounds as PI3Kα/mTOR dual inhibitors with improved pharmacokinetic properties and potent in vivo antitumor activity.
Liu Y; Xia Q; Fang L
Bioorg Med Chem; 2018 Aug; 26(14):3992-4000. PubMed ID: 29945756
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of irreversible EGFR tyrosine kinase inhibitors containing pyrido[3,4-d]pyrimidine scaffold.
Zhang H; Wang J; Zhao HY; Yang XY; Lei H; Xin M; Cao YX; Zhang SQ
Bioorg Med Chem; 2018 Jul; 26(12):3619-3633. PubMed ID: 29853340
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of aurora kinases inhibitors based on N-trisubstituted pyrimidine scaffold.
Long L; Luo Y; Hou ZJ; Ma HJ; Long ZJ; Tu ZC; Huang LJ; Liu Q; Lu G
Eur J Med Chem; 2018 Feb; 145():805-812. PubMed ID: 29358147
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of thieno[2,3-d]pyrimidine derivatives as novel dual c-Met and VEGFR-2 kinase inhibitors.
Li J; Gu W; Bi X; Li H; Liao C; Liu C; Huang W; Qian H
Bioorg Med Chem; 2017 Dec; 25(24):6674-6679. PubMed ID: 29146452
[TBL] [Abstract][Full Text] [Related]
30. "Prostate cancer is far more hidden…": Perceptions of stigma, social isolation and help-seeking among men with prostate cancer.
Ettridge KA; Bowden JA; Chambers SK; Smith DP; Murphy M; Evans SM; Roder D; Miller CL
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12790. PubMed ID: 29112317
[TBL] [Abstract][Full Text] [Related]
31. The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents.
Zuniga ES; Korkegian A; Mullen S; Hembre EJ; Ornstein PL; Cortez G; Biswas K; Kumar N; Cramer J; Masquelin T; Hipskind PA; Odingo J; Parish T
Bioorg Med Chem; 2017 Aug; 25(15):3922-3946. PubMed ID: 28576632
[TBL] [Abstract][Full Text] [Related]
32. Interplay of catalysis, fidelity, threading, and processivity in the exo- and endonucleolytic reactions of human exonuclease I.
Shi Y; Hellinga HW; Beese LS
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6010-6015. PubMed ID: 28533382
[TBL] [Abstract][Full Text] [Related]
33. Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies.
Singla P; Luxami V; Singh R; Tandon V; Paul K
Eur J Med Chem; 2017 Jan; 126():24-35. PubMed ID: 27744184
[TBL] [Abstract][Full Text] [Related]
34. Development of novel cyclic peptides as pro-apoptotic agents.
Brindisi M; Maramai S; Brogi S; Fanigliulo E; Butini S; Guarino E; Casagni A; Lamponi S; Bonechi C; Nathwani SM; Finetti F; Ragonese F; Arcidiacono P; Campiglia P; Valenti S; Novellino E; Spaccapelo R; Morbidelli L; Zisterer DM; Williams CD; Donati A; Baldari C; Campiani G; Ulivieri C; Gemma S
Eur J Med Chem; 2016 Jul; 117():301-20. PubMed ID: 27150036
[TBL] [Abstract][Full Text] [Related]
35. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
Deng J; Gou Y; Chen W; Fu X; Deng H
Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
[TBL] [Abstract][Full Text] [Related]
36. Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.
Nettekoven M; Adam JM; Bendels S; Bissantz C; Fingerle J; Grether U; Grüner S; Guba W; Kimbara A; Ottaviani G; Püllmann B; Rogers-Evans M; Röver S; Rothenhäusler B; Schmitt S; Schuler F; Schulz-Gasch T; Ullmer C
ChemMedChem; 2016 Jan; 11(2):179-89. PubMed ID: 26228928
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of novel condensed pyrrolo[1,2-c]pyrimidines featuring morpholine moiety as PI3Kα inhibitors.
Ibrahim MA; Abou-Seri SM; Hanna MM; Abdalla MM; El Sayed NA
Eur J Med Chem; 2015 Jun; 99():1-13. PubMed ID: 26037808
[TBL] [Abstract][Full Text] [Related]
38. Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM; Armstrong AJ; Rathkopf DE; Loriot Y; Sternberg CN; Higano CS; Iversen P; Bhattacharya S; Carles J; Chowdhury S; Davis ID; de Bono JS; Evans CP; Fizazi K; Joshua AM; Kim CS; Kimura G; Mainwaring P; Mansbach H; Miller K; Noonberg SB; Perabo F; Phung D; Saad F; Scher HI; Taplin ME; Venner PM; Tombal B;
N Engl J Med; 2014 Jul; 371(5):424-33. PubMed ID: 24881730
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and anticonvulsant activity evaluation of 7-substituted-[1,2,4]-triazolo[4,3-f]pyrimidine derivatives.
Guan LP; Sui X; Chang Y; Yan ZS; Tong GZ; Qu YL
Med Chem; 2012 Nov; 8(6):1076-83. PubMed ID: 22779795
[TBL] [Abstract][Full Text] [Related]
40. In vitro anti-leishmania evaluation of nickel complexes with a triazolopyrimidine derivative against Leishmania infantum and Leishmania braziliensis.
Ramírez-Macías I; Maldonado CR; Marín C; Olmo F; Gutiérrez-Sánchez R; Rosales MJ; Quirós M; Salas JM; Sánchez-Moreno M
J Inorg Biochem; 2012 Jul; 112():1-9. PubMed ID: 22542591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
